# Hypoxic Red Blood Cells in Sickle Cell Anemia

> **NCT06743113** · NA · NOT_YET_RECRUITING · sponsor: **Hemanext** · enrollment: 48 (estimated)

## Conditions studied

- Sickle Cell Anaemia
- Sickle Cell Anemia Crisis
- Sickle Cell Anemia in Children
- Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)

## Interventions

- **DEVICE:** Hemanext ONE System
- **DEVICE:** Conventional RBCs

## Key facts

- **NCT ID:** NCT06743113
- **Lead sponsor:** Hemanext
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-04
- **Final completion:** 2028-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06743113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06743113, "Hypoxic Red Blood Cells in Sickle Cell Anemia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06743113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*